June 28, 2023 — A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
June 26, 2023 — Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited ...
June 5, 2023 — The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic ...
March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...
February 8, 2023 — Life Molecular Imaging (LMI) announced that the first patient has been imaged with [18F]florbetaben i ...
January 5, 2023 — Mouaz H. Al-Mallah, MD, MSc, FASNC, director of the cardiovascular PET program at the Houston ...
December 1, 2022 —  A new method for determining whether patients with heart disease need coronary stents or bypass ...
November 17, 2022 — Cedars-Sinai investigators and colleagues have developed an artificial intelligence (AI) tool that ...
September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of ...
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...
August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...
August 12, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron ...
July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...
June 15, 2022 — Poor functional outcomes after a heart attack can be predicted with a new PET imaging agent, 68Ga-FAPI ...
June 28, 2023